SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-19-014791
Filing Date
2019-08-07
Accepted
2019-08-07 16:06:07
Documents
40
Period of Report
2019-06-30

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0619_anavexlifesciences.htm 10-Q 336770
2 CERTIFICATION f10q0619ex31-1_anavexlife.htm EX-31.1 7486
3 CERTIFICATION f10q0619ex31-2_anavexlife.htm EX-31.2 7383
4 CERTIFICATION f10q0619ex32-1_anavexlife.htm EX-32.1 4411
5 GRAPHIC img_001.jpg GRAPHIC 34863
6 GRAPHIC img_002.jpg GRAPHIC 29366
  Complete submission text file 0001213900-19-014791.txt   1811462

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE avxl-20190630.xml EX-101.INS 242404
8 XBRL SCHEMA FILE avxl-20190630.xsd EX-101.SCH 26118
9 XBRL CALCULATION FILE avxl-20190630_cal.xml EX-101.CAL 25527
10 XBRL DEFINITION FILE avxl-20190630_def.xml EX-101.DEF 75995
11 XBRL LABEL FILE avxl-20190630_lab.xml EX-101.LAB 198092
12 XBRL PRESENTATION FILE avxl-20190630_pre.xml EX-101.PRE 130059
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 10-Q | Act: 34 | File No.: 001-37606 | Film No.: 191005468
SIC: 8731 Services-Commercial Physical & Biological Research